½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1632609

¿þ½ºÅÏ ºí·ÎÆà ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹® ¿¹Ãø(2025-2030³â)

Western Blotting Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables), By Application (Biomedical & Biochemical Research, Disease Diagnostics), By End Use, By Region, And Segment Forecasts, 2025 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 120 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óÇ°Àº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¿þ½ºÅÏ ºí·ÎÆà ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ :

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é, ¼¼°èÀÇ ¿þ½ºÅÏ ºí·ÎÆà ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 27¾ï 8,000¸¸ ´Þ·¯¿¡ ´ÞÇßÀ¸¸ç, 2025³âºÎÅÍ 2030³â±îÁöÀÇ CAGRÀº 6.01%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. HIV °¨¿°ÀÚ ¼ö Áõ°¡°¡ ½ÃÀå ¼ºÀå¿¡ Á¡Á¡ ±â¿©ÇÏ°í ÀÖ½À´Ï´Ù. ÀÌ·± À¯ÇüÀÇ °Ë»ç´Â »ç¶÷µé »çÀÌ¿¡¼­ HIV¸¦ °ËÃâÇϴµ¥ ¸Å¿ì È¿°úÀûÀÔ´Ï´Ù. UNAIDS¿¡ µû¸£¸é 2015³â¿¡´Â ¼¼°è 3,670¸¸ ¸í °¡±îÀÌ HIV¿Í ÇÔ²² »ýÈ°Çß½À´Ï´Ù. ÀÌ·¯ÇÑ HIVÀÇ ³ôÀº À¯º´·üÀº ¿þ½ºÅÏ ºí·ÎÆÿ¡ »ç¿ëµÇ´Â Á¦Ç° ¼ö¿ä¸¦ °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶óÀÓ º´Àº ¶ÇÇÑ ±×·¯ÇÑ Áúº´À» ÀÏÀ¸Å°´Â º¸·¼¸®¾Æ ¹ö±× µ¹Æ丮(Bb)¸¦ °¨ÁöÇϱâ À§ÇØ ¿þ½ºÅÏ ºí·ÎÆÃÀÌ ÇÊ¿äÇÕ´Ï´Ù. ƯÁ¤ ´Ü¹éÁúÀ» °ËÃâÇϱâ À§ÇØ ¿þ½ºÅÏ ºí·ÎÆÃÀ» ÇÊ¿ä·Î ÇÏ´Â ´Ù¸¥ Áúº´Àº ±¤¿ìº´, °£¿°, °í¾çÀÌ ¸é¿ª °áÇÌÁõ µîÀ» Æ÷ÇÔÇÕ´Ï´Ù.

°Ô´Ù°¡ Á¦¾à±â¾÷°ú »ý¸í°øÇбâ¾÷¿¡ ÀÇÇÑ R&D È°µ¿¿¡ ´ëÇÑ ¾öû³­ ÅõÀÚ´Â ¿þ½ºÅÏ ºí·ÎÆà ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÇÑ ´º½º Àú³Î¿¡ µû¸£¸é, »ý¸í °øÇРȸ»ç´Â 2015³â R&D È°µ¿¿¡ 401¾ï ´Þ·¯¸¦ ÁöÃâÇßÀ¸¸ç, ÀÌ´Â 2014³â ÅõÀÚ ±Ý¾×¿¡¼­ 16% Áõ°¡Çß½À´Ï´Ù. µû¶ó¼­ ¿¬±¸°³¹ß È°µ¿ÀÌ Áõ°¡ÇÔ¿¡ µû¶ó °¡±î¿î ¹Ì·¡¿¡ ¿þ½ºÅÏ ºí·ÎÆà °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¿þ½ºÅÏ ºí·ÎÆà ½ÃÀå : ºÐ¼® °³¿ä

  • ¼Ò¸ðÇ° ºÎ¹®ÀÌ 2024³â ½ÃÀåÀ» µ¶Á¡Çß½À´Ï´Ù. ½Ã¾à, ¿ÏÃæ¾×, Ç×ü, ÄÁÁê°ÔÀÌÆ®, Å°Æ®, ¸âºê·¹ÀÎ, ÇÊÅÍ ¾Æ¿ô½ÃÆ® µîÀÇ ¼Ò¸ðÇ°Àº ÇÑ ¹øÀÇ »ç¿ë¿¡ ¸Â°Ô »ç¿ëÀÚ Á¤ÀÇÇÒ ¼ö ÀÖ½À´Ï´Ù.
  • Àåºñ ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È 4.66%ÀÇ »ó´çÇÑ CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • ¹ÙÀÌ¿À¸ÞµðÄà ¹× »ýÈ­ÇÐ ¿¬±¸ ºÎ¹®Àº 2024³â ¼öÀÍ Á¡À¯À²ÀÌ 61.59%·Î ¾÷°è¸¦ Áö¹èÇß½À´Ï´Ù.
  • Çмú ¹× ¿¬±¸ ±â°ü ºÎ¹®Àº 2024³â ¼öÀÍ Á¡À¯À² 35.15%·Î ½ÃÀåÀ» µ¶Á¡Çß½À´Ï´Ù. ÀÌ ºÎ¹®Àº ±âº» ¿¬±¸, ´Ü¹éÁú ¿¬±¸, »ýüºÐÀÚ ºÐ¼®¿¡ ¿þ½ºÅÏ ºí·ÎÆÃÀÌ ³Î¸® »ç¿ëµÇ°í Àֱ⠶§¹®¿¡ ½ÃÀåÀÇ ÁÖ¿ä ÃÖÁ¾ ¿ëµµ ºÎ¹®ÀÌ µÇ°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ºÐ¼® ¹æ¹ý¡¤¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¿þ½ºÅÏ ºí·ÎÆà ½ÃÀå : º¯µ¿ ¿äÀΡ¤°æÇ⡤¹üÀ§

  • ½ÃÀå ¿¬°ü Àü¸Á
    • »óÀ§ ½ÃÀå Àü¸Á
    • °ü·Ã/ºÎ¼ö ½ÃÀå Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
  • ¾÷°è ºÐ¼® Åø
    • Porter's Five Forces ºÐ¼®
    • PESTEL ºÐ¼®
    • COVID-19ÀÇ ¿µÇ⠺м®

Á¦4Àå ¿þ½ºÅÏ ºí·ÎÆà ½ÃÀå : Á¦Ç°º° ÃßÁ¤¡¤µ¿Ç⠺м®

  • Á¦Ç°º° ´ë½Ãº¸µå
  • ¼¼°èÀÇ ¿þ½ºÅÏ ºí·ÎÆà ½ÃÀåÀÇ º¯µ¿ ºÐ¼® : Á¦Ç°º°
  • ¼¼°èÀÇ ¿þ½ºÅÏ ºí·ÎÆà ½ÃÀå : ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м®, Á¦Ç°º°(2018-2030³â)
  • ÀåÄ¡
    • °Ö Àü±â¿µµ¿ÀåÄ¡
    • ºí·ÎÆà ½Ã½ºÅÛ
    • È­»ó ÀåÄ¡
  • ¼Ò¸ðÇ°
    • ½Ã¾à
    • Å°Æ®

Á¦5Àå ¿þ½ºÅÏ ºí·ÎÆà ½ÃÀå : ¿ëµµº° ÃßÁ¤¡¤µ¿Ç⠺м®

  • ¿ëµµº° ´ë½Ãº¸µå
  • ¼¼°èÀÇ ¿þ½ºÅÏ ºí·ÎÆà ½ÃÀåÀÇ º¯µ¿ ºÐ¼® : ¿ëµµº°
  • ¼¼°èÀÇ ¿þ½ºÅÏ ºí·ÎÆà ½ÃÀå : ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м®, ¿ëµµº°(2018-2030³â)
  • »ý¹°ÀÇÇС¤»ýÈ­ÇÐ ¿¬±¸
  • Áúº´ Áø´Ü
  • ³ó¾÷
  • ±âŸ

Á¦6Àå ¿þ½ºÅÏ ºí·ÎÆà ½ÃÀå : ÃÖÁ¾ ¿ëµµº° ÃßÁ¤¡¤µ¿Ç⠺м®

  • ÃÖÁ¾ ¿ëµµº° ´ë½Ãº¸µå
  • ¼¼°èÀÇ ¿þ½ºÅÏ ºí·ÎÆà ½ÃÀåÀÇ º¯µ¿ ºÐ¼® : ÃÖÁ¾ ¿ëµµº°
  • ¼¼°èÀÇ ¿þ½ºÅÏ ºí·ÎÆà ½ÃÀå : ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м®, ÃÖÁ¾ ¿ëµµº°(2018-2030³â)
  • Çмú¿¬±¸±â°ü
  • Á¦¾à¡¤¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
  • Áø´Ü¼¾ÅÍ
  • ±âŸ

Á¦7Àå ¿þ½ºÅÏ ºí·ÎÆà ½ÃÀå : Áö¿ªº° ÃßÁ¤¡¤µ¿Ç⠺м®

  • ½ÃÀå Á¡À¯À² ºÐ¼® : Áö¿ªº°(2024³â¡¤2030³â)
  • ½ÃÀå ´ë½Ãº¸µå : ½ÃÀ庰
  • ½ÃÀå ±Ô¸ð ¿¹Ãø°ú µ¿Ç⠺м®(2018-2030³â)
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • µ§¸¶Å©
    • ½º¿þµ§
    • ³ë¸£¿þÀÌ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • ű¹
    • Çѱ¹
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¾Æ¸£ÇîƼ³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • Äí¿þÀÌÆ®

Á¦8Àå °æÀï ±¸µµ

  • ½ÃÀå ÁøÃâ±â¾÷
  • ±â¾÷ ½ÃÀå Æ÷Áö¼Ç ºÐ¼®(2024³â)
  • ½ÃÀå ÁøÃâ±â¾÷ÀÇ °³¿ä
    • Thermo Fisher Scientific Inc.
    • Bio-Rad Laboratories, Inc.
    • LI-COR, Inc.
    • Merck KGaA
    • F. Hoffmann-La Roche Ltd.
    • Bio-Techne Corporation
    • GE HealthCare
    • QIAGEN
    • Advansta Inc.
    • Cell Signaling Technology, Inc.
KTH 25.02.28

Western Blotting Market Growth & Trends:

The global western blotting market size is expected to reach USD 2.78 billion by 2030, registering a CAGR of 6.01% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising number of cases with HIV are increasingly contributing towards the growth of market. This kind of testing is highly effective in detecting HIV among people. According to UNAIDS, nearly 36.7 million people were living with HIV throughout the world in 2015. Such high prevalence of HIV is expected to accelerate the demand for products used in western blotting. Lyme diseases also require western blotting to detect Borrelia burgdorferi (Bb), which causes such diseases. Other diseases which require western blot for detection of specific proteins include mad cow disease, hepatitis, and feline immunodeficiency.

Moreover, significant investments in R&D activities made by pharmaceutical and biotechnology companies are expected to foster growth of western blotting market. According to a news journal, biotech companies spent USD 40.1 billion in 2015 on R&D activities, which was a 16% rise from their 2014 investments. Hence, with rising number of R&D activities, there is an expected rise in the demand for western blotting tests in the near future.

Western Blotting Market Report Highlights:

  • The consumables segment dominated the market in 2024. Consumables such as reagents, buffers, antibodies, conjugates, kits, membranes, and filter-out sheets can be customized for a single use.
  • The instrument segment is expected to register a significant CAGR of 4.66% over the forecast period.
  • The biomedical & biochemical research segment dominated the industry with a revenue share of 61.59% in 2024.
  • The academic & research institute segment dominated the market with a revenue share of 35.15% in 2024. The segment has been the leading end-use segment in the market due to its widespread use of western blotting for fundamental research, protein studies, and biomolecular analysis.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End Use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Western Blotting Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing prevalence of chronic and infectious diseases
      • 3.2.1.2. Advancements in proteomics research
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High costs of instruments and reagents
      • 3.2.2.2. Emergence of alternative technologies
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Western Blotting Market: Product Estimates & Trend Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Global Western Blotting Market Product Movement Analysis
  • 4.3. Global Western Blotting Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Instruments
    • 4.4.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Gel Electrophoresis Instruments
      • 4.4.2.1. Gel Electrophoresis Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Blotting Systems
      • 4.4.3.1. Blotting Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.3.2. Semi-Dry Blotting Instruments
        • 4.4.3.2.1. Semi-Dry Blotting Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.3.3. Wet Blotting Instruments
        • 4.4.3.3.1. Wet Blotting Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Imagers
      • 4.4.4.1. Imagers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.4.2. Chemiluminescent Imagers
        • 4.4.4.2.1. Chemiluminescent Imagers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.4.3. Fluorescent Imagers
        • 4.4.4.3.1. Fluorescent Imagers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.4.4. Others
        • 4.4.4.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Consumables
    • 4.5.1. Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Reagents
      • 4.5.2.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Kits
      • 4.5.3.1. Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Western Blotting Market: Application Estimates & Trend Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. Global Western Blotting Market Application Movement Analysis
  • 5.3. Global Western Blotting Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Biomedical & Biochemical Research
    • 5.4.1. Biomedical & Biochemical Research Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Disease Diagnostics
    • 5.5.1. Disease Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Agriculture
    • 5.6.1. Agriculture Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Western Blotting Market: End Use Estimates & Trend Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. Global Western Blotting Market End Use Movement Analysis
  • 6.3. Global Western Blotting Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Academic & Research Institutes
    • 6.4.1. Academic & Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Pharmaceutical & Biotechnology Companies
    • 6.5.1. Pharmaceutical & Biotechnology Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Diagnostic Centers
    • 6.6.1. Diagnostic Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Western Blotting Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 7.4. North America
    • 7.4.1. North America Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. U.S. Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Canada Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Mexico Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. UK Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Germany Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. France Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Italy Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Spain Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Denmark Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Sweden Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Norway Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Japan Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. China Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. India Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Australia Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Thailand
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Thailand Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. South Korea
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. South Korea Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Brazil Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Argentina Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. South Africa Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Saudi Arabia Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. UAE Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Kuwait Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Categorization
  • 8.2. Company Market Position Analysis, 2024
  • 8.3. Participant's Overview
    • 8.3.1. Thermo Fisher Scientific Inc.
      • 8.3.1.1. Participant's Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Product Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. Bio-Rad Laboratories, Inc.
      • 8.3.2.1. Participant's Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Product Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. LI-COR, Inc.
      • 8.3.3.1. Participant's Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Product Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. Merck KGaA
      • 8.3.4.1. Participant's Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Product Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. F. Hoffmann-La Roche Ltd.
      • 8.3.5.1. Participant's Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Product Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Bio-Techne Corporation
      • 8.3.6.1. Participant's Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Product Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. GE HealthCare
      • 8.3.7.1. Participant's Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Product Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. QIAGEN
      • 8.3.8.1. Participant's Overview
      • 8.3.8.2. Financial Performance
      • 8.3.8.3. Product Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. Advansta Inc.
      • 8.3.9.1. Participant's Overview
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Product Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. Cell Signaling Technology, Inc.
      • 8.3.10.1. Participant's Overview
      • 8.3.10.2. Financial Performance
      • 8.3.10.3. Product Benchmarking
      • 8.3.10.4. Strategic Initiatives
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦